is the fda banning bpc 157 Panel Recommends Compounding Unapproved Peptides why did the fda ban

Presented for research literature review only Saito S et al

A 2010 study by Tudor and colleagues in Regulatory Peptides reported that BPC-157 at 10 g/kg or 10 ng/kg i.p., given 30 minutes before falling-weight traumatic brain injury in mice, directionally reduced unconsciousness and mortality across force impulses of 0.0680.145 Ns, with the higher dose effective at the maximum 0.159 Ns impulse though the abstract does not report numeric mortality percentages or p-values

Neuroprotective effects: One study suggested the peptide may counteract damage caused by paracetamol-induced convulsions and brain damage in rats (2)

Older Adults As we age, the bodys ability to absorb B12 from food decreases, making supplementation essential

Potential benefits include: Improved digestive function Reduced inflammation Support for the gut-brain axis Enhanced overall resilience to stress Research Limitations Most anxiety-related findings come from animal research, and more human studies are necessary